+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vital Proteins for Biomanufacturing Market by Groups, Function, Indication - Global Forecast 2025-2030- Product Image
Vital Proteins for Biomanufacturing Market by Groups, Function, Indication - Global Forecast 2025-2030- Product Image
Sale

Vital Proteins for Biomanufacturing Market by Groups, Function, Indication - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5889105
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Vital Proteins for Biomanufacturing Market grew from USD 52.10 billion in 2023 to USD 56.52 billion in 2024. It is expected to continue growing at a CAGR of 8.92%, reaching USD 94.81 billion by 2030.

The scope of vital proteins in biomanufacturing encompasses their essential role as scaffolds, cell culture mediums, and stabilizers in biological production processes. Their unique amino acid sequences and physicochemical properties make them indispensable for supporting cell growth and facilitating bioprocess efficiency. The necessity of these proteins lies in their ability to enhance product yield and quality, reduce contamination risk, and expedite the manufacturing of biologics, including vaccines, enzymes, and therapeutic antibodies. With an end-use scope that spans pharmaceuticals, diagnostics, and cellular agriculture, the market for biomanufactured vital proteins is poised for substantial growth. Key factors driving this expansion include advancements in synthetic biology, increasing demand for biologics, and a shift towards sustainable production methods. However, potential opportunities are emerging in customizable protein engineering, where tailored properties can optimize efficiency for specific bioprocesses. Investments in R&D to develop animal-free alternatives also present a significant opportunity given the rising emphasis on ethical and sustainable manufacturing. Despite these prospects, challenges such as high production costs, stringent regulatory requirements, and technical complexities in mass production persist. The need for sophisticated infrastructure and expertise also limits widespread adoption, posing a hurdle to market growth. Innovations in recombinant DNA technology and fermentation processes present potential areas for exploration, offering cost-effective and scalable solutions. Moreover, advancements in bioinformatics and machine learning can propel protein design, optimizing their functional attributes. The market is characterized by a competitive landscape with key players continuously innovating to gain a competitive edge. Thus, for businesses, strategic collaborations and an emphasis on innovation, particularly in sustainable and scalable production techniques, could yield significant advantages. Consequently, understanding market dynamics and investing in technological advancements will be crucial to harnessing growth in the vital proteins for biomanufacturing sector, a niche field with vast potential yet inherent complexities.

Understanding Market Dynamics in the Vital Proteins for Biomanufacturing Market

The Vital Proteins for Biomanufacturing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing demand for biopharmaceuticals with enhanced therapeutic efficacy
    • Rapid adoption of novel cell culture platforms to produce complex biotherapeutics
    • Growing interest in personalized medicine necessitates tailored protein therapeutics
  • Market Restraints
    • High capital expenditure requirements for establishing state-of-the-art biomanufacturing facilities
  • Market Opportunities
    • Supportive government policies promoting investments in research & development
    • Ongoing collaborations between academia & industry players for technological innovations in vital proteins
  • Market Challenges
    • Complexities associated with scaling up production processes

Exploring Porter’s Five Forces for the Vital Proteins for Biomanufacturing Market

Porter’s Five Forces framework further strengthens the insights of the Vital Proteins for Biomanufacturing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Vital Proteins for Biomanufacturing Market

External macro-environmental factors deeply influence the performance of the Vital Proteins for Biomanufacturing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Vital Proteins for Biomanufacturing Market

The Vital Proteins for Biomanufacturing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Vital Proteins for Biomanufacturing Market

The Vital Proteins for Biomanufacturing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Vital Proteins for Biomanufacturing Market

The Vital Proteins for Biomanufacturing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vital Proteins for Biomanufacturing Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Abnova Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioLegend, Inc. by PerkinElmer, Inc., Biologics International Corporation, BPS Bioscience, Inc., Bristol-Myers Squibb Company, Creative BioMart Inc., Croyez Bioscience Co., Ltd., Eli Lilly and Company, Enzo Life Sciences, Inc., GenScript Biotech Corporation, Johnson & Johnson Services, Inc., Laurus Bio Private Limited, LenioBio GmbH, Lonza Group AG, Merck KGaA, Meridian Bioscience, Inc. by SD Biosensor Inc., Miltenyi Biotec B.V. & Co. KG, Novartis AG, ProMab Biotechnologies, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Vital Proteins for Biomanufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Groups
    • Cytokines
      • Chemokines
      • Colony-stimulating factors
      • Interferons
      • Interleukins
      • Tumor necrosis factors
    • Enzymes & Chemicals
      • DNA Capping Enzymes
      • Endonucleases
      • Glycosidases
      • Polyadenylation Enzymes
      • Protease Inhibitors
      • Transcription Enzymes
    • Expression Systems
      • Bacterial
      • Insect
      • Mammalian Cells
      • Yeast
    • Media & Supplements
      • Albumin
      • Epidermal Growth Factor (EGF)
      • Fibroblast Growth Factors (FGFs)
      • Insulin-like Growth Factors (IGFs)
      • Transferrin
      • Vascular Endothelial Growth Factor (VEGF)
    • Protein A Resins
    • Quality Control Reagents
    • Vectors & Transfection Reagents
  • Function
    • Diagnostics
    • Drug Discovery & Development
      • Biologics
      • Cell & Gene Therapy
      • Vaccines
  • Indication
    • Autoimmune Disorders
    • Infectious Diseases
    • Oncology
    • Rare Genetic Disorders
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for biopharmaceuticals with enhanced therapeutic efficacy
5.1.1.2. Rapid adoption of novel cell culture platforms to produce complex biotherapeutics
5.1.1.3. Growing interest in personalized medicine necessitates tailored protein therapeutics
5.1.2. Restraints
5.1.2.1. High capital expenditure requirements for establishing state-of-the-art biomanufacturing facilities
5.1.3. Opportunities
5.1.3.1. Supportive government policies promoting investments in research & development
5.1.3.2. Ongoing collaborations between academia & industry players for technological innovations in vital proteins
5.1.4. Challenges
5.1.4.1. Complexities associated with scaling up production processes
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Vital Proteins for Biomanufacturing Market, by Groups
6.1. Introduction
6.2. Cytokines
6.2.1. Chemokines
6.2.2. Colony-stimulating factors
6.2.3. Interferons
6.2.4. Interleukins
6.2.5. Tumor necrosis factors
6.3. Enzymes & Chemicals
6.3.1. DNA Capping Enzymes
6.3.2. Endonucleases
6.3.3. Glycosidases
6.3.4. Polyadenylation Enzymes
6.3.5. Protease Inhibitors
6.3.6. Transcription Enzymes
6.4. Expression Systems
6.4.1. Bacterial
6.4.2. Insect
6.4.3. Mammalian Cells
6.4.4. Yeast
6.5. Media & Supplements
6.5.1. Albumin
6.5.2. Epidermal Growth Factor (EGF)
6.5.3. Fibroblast Growth Factors (FGFs)
6.5.4. Insulin-like Growth Factors (IGFs)
6.5.5. Transferrin
6.5.6. Vascular Endothelial Growth Factor (VEGF)
6.6. Protein A Resins
6.7. Quality Control Reagents
6.8. Vectors & Transfection Reagents
7. Vital Proteins for Biomanufacturing Market, by Function
7.1. Introduction
7.2. Diagnostics
7.3. Drug Discovery & Development
7.3.1. Biologics
7.3.2. Cell & Gene Therapy
7.3.3. Vaccines
8. Vital Proteins for Biomanufacturing Market, by Indication
8.1. Introduction
8.2. Autoimmune Disorders
8.3. Infectious Diseases
8.4. Oncology
8.5. Rare Genetic Disorders
9. Americas Vital Proteins for Biomanufacturing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Vital Proteins for Biomanufacturing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Vital Proteins for Biomanufacturing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. New England Biolabs Introduces Faustovirus Capping Enzyme, a Novel Enzymatic mRNA Capping Solution for mRNA Manufacturing
12.3.2. Everest Medicines Ltd. acquires rights to 3C-like protease inhibitors to develop antivirals for COVID-19
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. VITAL PROTEINS FOR BIOMANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2023 VS 2030 (%)
FIGURE 7. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. VITAL PROTEINS FOR BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. VITAL PROTEINS FOR BIOMANUFACTURING MARKET DYNAMICS
TABLE 7. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CHEMOKINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COLONY-STIMULATING FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INTERFERONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INTERLEUKINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TUMOR NECROSIS FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DNA CAPPING ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENDONUCLEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GLYCOSIDASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY POLYADENYLATION ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TRANSCRIPTION ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INSECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY YEAST, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EPIDERMAL GROWTH FACTOR (EGF), BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FIBROBLAST GROWTH FACTORS (FGFS), BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INSULIN-LIKE GROWTH FACTORS (IGFS), BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TRANSFERRIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEIN A RESINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY QUALITY CONTROL REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY VECTORS & TRANSFECTION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY RARE GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 78. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 79. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 80. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 81. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 82. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 83. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 84. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 87. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 88. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 90. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 91. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 92. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 120. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 121. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 122. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 123. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 124. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 125. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 126. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 128. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 129. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 130. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 131. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 132. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 133. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 134. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 136. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 138. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 143. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 144. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 145. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 146. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 147. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 148. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 149. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 150. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 151. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 152. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 153. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 154. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 156. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 160. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 161. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 162. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 163. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 164. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 165. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 167. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 168. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 169. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 170. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 171. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 172. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 173. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 174. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 175. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 176. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 177. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 178. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 179. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 180. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 181. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 182. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 183. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 184. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 185. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 186. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 187. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 188. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 189. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 190. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 192. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 193. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 194. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 195. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 196. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 197. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 198. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 200. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 201. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 202. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 203. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 204. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 205. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 206. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 216. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 217. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 218. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 219. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 220. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 221. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 222. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 223. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 224. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 225. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 226. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 227. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 228. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 229. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 230. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 231. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 232. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 233. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 234. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 235. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 236. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 237. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 238. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 239. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 240. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 241. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 242. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 243. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 244. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 245. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 246. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 247. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 248. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 249. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 250. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 251. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 252. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 253. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 254. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 255. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 256. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 257. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 258. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 259. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 264. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 265. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 266. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 267. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 268. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 269. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 270. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 271. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 273. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 274. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 275. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 276. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 277. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 278. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 279. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 280. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 281. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 288. NORWAY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
TABLE 289. NORWAY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
TABLE 290. NORW

Companies Mentioned

The leading players in the Vital Proteins for Biomanufacturing Market, which are profiled in this report, include:
  • Abcam PLC
  • Abnova Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioLegend, Inc. by PerkinElmer, Inc.
  • Biologics International Corporation
  • BPS Bioscience, Inc.
  • Bristol-Myers Squibb Company
  • Creative BioMart Inc.
  • Croyez Bioscience Co., Ltd.
  • Eli Lilly and Company
  • Enzo Life Sciences, Inc.
  • GenScript Biotech Corporation
  • Johnson & Johnson Services, Inc.
  • Laurus Bio Private Limited
  • LenioBio GmbH
  • Lonza Group AG
  • Merck KGaA
  • Meridian Bioscience, Inc. by SD Biosensor Inc.
  • Miltenyi Biotec B.V. & Co. KG
  • Novartis AG
  • ProMab Biotechnologies, Inc.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages187
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 56.52 Billion
Forecasted Market Value ( USD ) by 2030 $ 94.81 Billion
Compound Annual Growth Rate8.9%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Next-Generation Biomanufacturing Market by Type, Application, End-User - Global Forecast 2025-2030 - Product Image

Next-Generation Biomanufacturing Market by Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Digital Biomanufacturing Market by Deployment, Application, End-use - Global Forecast 2025-2030 - Product Image

Digital Biomanufacturing Market by Deployment, Application, End-use - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
The Global Market for Industrial Biomanufacturing 2025-2035 - Product Image

The Global Market for Industrial Biomanufacturing 2025-2035

  • Report
  • 1159 Pages
  • Global
The Global Biomanufacturing Market 2024-2035 - Product Image

The Global Biomanufacturing Market 2024-2035

  • Report
  • 1175 Pages
  • Global
Digital Biomanufacturing Global Market Report 2024 - Product Image

Digital Biomanufacturing Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.